Marker, Søren http://orcid.org/0000-0003-3602-4541
,
Perner, Anders
Wetterslev, Jørn
Krag, Mette
Lange, Theis
Wise, Matt P.
Borthwick, Mark
Bendel, Stepani
Keus, Frederik
Guttormsen, Anne Berit
Schefold, Joerg C.
Møller, Morten Hylander
Article History
Received: 20 November 2018
Accepted: 28 February 2019
First Online: 12 March 2019
Compliance with ethical standards
:
: None for the present study. The Department of Intensive Care at Rigshospitalet receives support for other research projects from Fresenius Kabi, Germany; CSL Behring, Switzerland; Ferring Pharmaceuticals, Denmark; and the Novo Nordisk Foundation, Denmark. The authors report no conflicts of interest. All authors were involved in the conduct of the SUP-ICU trial.
: No additional approvals were needed for this post hoc sub-analysis of the SUP-ICU trial. All procedures in the SUP-ICU trial were performed in accordance with the ethical standards of the institutional and/or national research committees and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.
Free to read: This content has been made available to all.